Dr. Michener is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273Fax+1 216-444-8551- Is this information wrong?
Summary
- -Vice Chair, Obstetrics & Gynecology Institute
-Medical Director of Continuous Improvement for the Obstetrics & Gynecology Institute
-Professor of Ob/Gyn & Reproductive Biology Cleveland Clinic Lerner College of Medicine of Case Western University.
-Fellow, American College of Obstetricians and Gynecologists and a member of the Society of Gynecologic Oncologists.
-Staff, Gynecologic Oncology
Education & Training
- Cleveland Clinic FoundationFellowship, Gynecologic Oncology, 2002 - 2004
- National Cancer InstitutePost-Doctoral Fellowship, Molecular signaling , 2001 - 2002
- TriHealth (Bethesda Hospital)Residency, Obstetrics and Gynecology, 1997 - 2001
- Wright State University Boonshoft School of MedicineClass of 1997
Certifications & Licensure
- OH State Medical License 1998 - 2024
- MD State Medical License 2001 - 2003
- KY State Medical License 1999 - 2000
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Randomized Phase II Study of Intravenous 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine® NSC #663249) Cisplatin-Radiochemotherapy Versus Intravenous Cisplatin-Radiochemotherapy in Women Diagnosed With Stage IB-IVA Cervical Cancer and S Start of enrollment: 2013 Apr 01
- Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery Start of enrollment: 2013 Jul 01
- A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) Start of enrollment: 2019 Mar 20
- Join now to see all
Publications & Presentations
PubMed
- Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial.Anthony B Costales, Erin K Crane, Laura Chambers, Meng Yao, Danielle Chau, Wendel R Naumann, Robert Debernardo, Stephanie Ricci, Peter G Rose, Chad M Michener> ;Gynecologic Oncology. 2024 Feb 27
- Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer.Simpson, P., Zhang, L., Christian, Q., Uyar, D., Michener, C., Bishop, E., Hopp, E., Rader, J., Rose, P., Mahdi, H., Debernardo, R., Bradley, W.> ;Frontiers in Oncology. 2024 Jan 1
- 1 citationsAssociation of Clinical Trial Participation With Improved Overall Survival for Recurrent, Platinum-Resistant Ovarian Cancer.Molly Morton, Meng Yao, Julia Chalif, Erika J Lampert, Danielle Chau, Peter G Rose, Chad M Michener, Roberto Vargas, Laura M Chambers, Debernardo, R.> ;Obstetrics and Gynecology. 2023 Sep 1
- Join now to see all
Press Mentions
- Hillcrest Hospital Opens New Obstetrics Emergency DepartmentNovember 26th, 2021
- Cleveland Clinic Names Tristi Muir, M.D., Chair of Ob/Gyn & Women’s Health InstituteSeptember 8th, 2021
- Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) (ART-CIN_IIB)September 23rd, 2019
- Join now to see all
Professional Memberships
- Fellow
- Member
- Society of Gynecologic OncologyMember
Hospital Affiliations
- Cleveland ClinicCleveland, Ohio
- Cleveland Clinic Fairview HospitalCleveland, Ohio
- Cleveland Clinic Hillcrest HospitalCleveland, Ohio
External Links
- Cleveland Clinichttps://my.clevelandclinic.org/staff/4865-chad-michener
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: